Demant Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Demant heeft een totaal eigen vermogen van DKK9.5B en een totale schuld van DKK13.1B, wat de schuld-eigenvermogensverhouding op 137.5% brengt. De totale activa en totale passiva bedragen respectievelijk DKK32.4B en DKK22.9B. De EBIT Demant is DKK4.0B waardoor de rentedekking 7.8 is. Het heeft contanten en kortetermijnbeleggingen van DKK1.0B.

Belangrijke informatie

137.5%

Verhouding schuld/eigen vermogen

DKK 13.10b

Schuld

Rente dekkingsratio	7.8x
Contant	DKK 1.05b
Aandelen	DKK 9.52b
Totaal verplichtingen	DKK 22.87b
Totaal activa	DKK 32.39b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( DKK10.7B ) DEMANC } overtreffen de korte termijn passiva ( DKK7.5B ).

Langlopende schulden: De kortetermijnactiva van DEMANC ( DKK10.7B ) dekken de langetermijnschulden ( DKK15.4B ) niet.

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 126.5% ) DEMANC wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van DEMANC is de afgelopen 5 jaar gestegen van 95.3% naar 137.5%.

Schuldendekking: De schuld van DEMANC wordt goed gedekt door de operationele kasstroom ( 27.8% ).

Rentedekking: De rentebetalingen op de schuld van DEMANC worden goed gedekt door EBIT ( 7.8 x dekking).

Demant Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

Demant A/S Appoints Anne-Karen Hunt as President of Diagnostics Business Area, Effective 1 November 2024

Demant A/S Announces Board Changes

Demant A/S Updates Earnings Guidance for the Year 2024

Cochlear Limited (ASX:COH) acquired Oticon Medical A/s from Demant A/S (CPSE:DEMANT).

Cochlear Limited (ASX:COH) acquired Oticon Medical A/s from Demant A/S (CPSE:DEMANT).

Less than half of directors are independent

Demant A/S Provides Earnings Guidance for the Year 2024

Investor sentiment improves as stock rises 21%

Anja Madsen Announces Not to Stand for Re-Election to the Board of Directors of Demant A/S

Less than half of directors are independent

Demant A/S to Report Nine Months, 2024 Results on Nov 04, 2024

Less than half of directors are independent

Demant A/S Provides Earnings Guidance for the Year 2023

Less than half of directors are independent

Now 21% undervalued

Demant A/S Announces Executive Changes

Less than half of directors are independent

Investor sentiment improves as stock rises 16%

Less than half of directors are independent

Now 22% undervalued

Less than half of directors are independent

Less than half of directors are independent

Demant A/S to Report Fiscal Year 2022 Results on Feb 07, 2023

Less than half of directors are independent

Demant A/S Revised Earnings Guidance for the Full Year of 2022

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Demant A/S Revises Earnings Guidance for the Full Year 2022

Less than half of directors are independent

Less than half of directors are independent

Demant A/S (CPSE:DEMANT) acquired remaining 80% interest in ShengWang for CNY.

Less than half of directors are independent

Demant A/S Appoints Niels Wagner to the Board of Directors

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Less than half of directors are independent

Demant A/S Announces Update on Voluntary Field Corrective Action

Less than half of directors are independent

Demant A/Sreiterated Guidance for the Year 2021

Less than half of directors are independent

Less than half of directors are independent

Demant A/S Updates Earnings Guidance for the Year 2021

Independent Director has left the company

Independent Director has left the company

New 90-day high: kr.263

Full year 2020 earnings released: EPS kr.4.68 (vs kr.6.00 in FY 2019)

Revenue beats expectations

Demant A/S Announces Executive Changes

New 90-day high: kr.237

Demant Launches New Flagship Hearing aids

New 90-day high: kr.235

Demant A/S, Annual General Meeting, Mar 05, 2021

Demant A/S Revises Earnings Guidance for the Second Half of Fiscal Year 2020

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven